Newron Pharmaceuticals Aktie
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 88,61 |
| Tobias Scherer | 5,66 |
| UBS Asset Management Switzerland AG | 3,08 |
| Jeffrey S. Yass | 2,86 |
| Gefim SpA | 2,86 |
| Swisscanto (CH) Index Fund V - Equity Fd. Switzerland To. Res. | 0,68 |
| Swisscanto (CH) Index Fund V - Equity Small & Mids Caps Swit. | 0,63 |
| CSIF (CH) Umbrella - Eq. Switzerland Total Market Index Blue | 0,59 |
| CSIF (CH) Umbrella - Equity Switzerland Small & Mid Cap | 0,55 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. CHF) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 65 | 41 | 41 | 28 | 18 |
| Summe Anlagevermögen | 0 | 14 | 11 | 9 | 6 |
| Summe Aktiva | 66 | 55 | 52 | 37 | 24 |
Bilanz (in Mio. CHF) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 26 | 37 | 49 | 51 | 52 |
| Summe Eigenkapital | 40 | 19 | 3 | -14 | -28 |
| Summe Passiva | 66 | 55 | 52 | 37 | 24 |
Adresse
| via Antonio Meucci 3, 20091 Bresso | |
| Telefon | +39 (02) 610-3461 |
| Fax | +39 (02) 610-34654 |
| Internet | https://www.newron.com/ |
Management
|
Dennis Dionne
Vice President-Commercial Affairs |
|
Filippo Moriggia
Vice President-Operations |
|
Gillian Dines
Non-Executive Director |
|
Laura Faravelli
Executive Vice President-Business Development |
|
Luca Benatti
Independent Non-Executive Director |
|
Margarita I. Chavez
Independent Director |
|
Patrick J. Langlois
Independent Non-Executive Director |
|
Ravi Anand
Chief Medical Officer |
|
Roberto Galli
Chief Financial Officer |
|
Stefan Weber
Chief Executive Officer & Director |
|
Ulrich Köstlin
Non-Executive Chairman |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
